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MALIGNANT AND NON-MALIGNANT UTERINE
AND VAGINAL LESIONS IN MICE RECEIVING
ESTROGENS AND ESTROGENS AND
ANDROGENS SIMULTANEOUSLY*
W. U. GARDNER AND E. ALLEN
Atypical uterine conditions, particularly those classified as
glandular cystic hyperplasia and fibroids, have been considered to
follow altered ovarian function or endocrine imbalance.' Direct
experiments have demonstrated that these conditions could be more
or less completely reproduced in one or more species of laboratory
animals if estrogens were administered over prolonged periods.2
Malignant neoplasms have not been so generally observed,
however. Lesions, histologically malignant, precancerous, or can-
cer-like were reported by several investigators as appearing in mice
which had received estrogens3`7 or estrogens and carcinogens simul-
taneously.8 Most of these lesions were small. Though showing
varying degrees of invasiveness, metastases were not observed.
Because of their usual small size they were not diagnosed during life
to determine the possibility of regression following the cessation of
estrogenic injections. A transplantable, metastasizing carcinoma,
presumably of cervical origin, occurred in one mouse receiving estro-
gen.9 Eighteen other mic- were mentioned as showing probable
earlier stages of the same malignant process or "precancerous"
changes. The above observations indicated that estrogens played a
r8le in cervical malignancies. These lesions were apparently inde-
pendent of known genetic factors.7
Materias and Methods
Female mice from eight different inbred strains were used in the present
study. These strains had been maintained for many generations of close
inbreeding. With regard to the incidence of development of mammary
tumors marked variations existed between the different strains. These strains
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(C3H, A, CBA, C12I, F, C57, N, and JK) were generously supplied from
the colony of Dr. L. C. Strong.
Several different estrogenic chemicals* have been used, estradiol benzoate,
equilin, equilin benzoate, equilenin benzoate, estradiol dipropionate, and
stilbestrol. Progesterone and testosterone propionate were other sex hor-
mones used. All of these substances were dissolved in sesame oil and injected
into the dorsal tissues subcutaneously. The concentrations of the hormones
were usually so arranged that 0.05 cc. was administered per injection. Injec-
tions were usually made at weekly intervals, though in some experiments
at shorter or longer intervals.
Control mice were either untreated, given weekly injections of sesame
oil or sesame oil containing cholesterol or cholesterol benzoate. All mice were
maintained on Purina Fox Chow.
Mammary tumors frequently developed in mice of some of the strains
receiving estrogens and in several cases they were removed under general
anesthesia.
TI he uterus, cervix, and vagina were removed intact at autopsy and fixed
in Bouin's fluid or 10 per cent formalin. The lower portion of the uterine
horns, cervix, and upper vagina were sectioned serially, and 2 of every 12
sections were mounted and stained. One area of each uterine horn, usually
from the central portion, was also sectioned. Test sections through the
cervices and the vaginas were examined in many of the controls.
Observations were made on the size and gross appearance of the genital
tissues at the tinrle of autopsy. All of the mice were observed daily during
the course of the experiment and carefully examined once or twice each week.
The mice were usually killed when mammary or lymphoid tumors appeared
or when their general condition did not warrant their continuance. Cervical
or upper vaginal tumors were diagnosed prior to autopsy in only three mice.
The smaller epithelial tumors or invasions of the genital tissues in this region
were only apparent after microscopic study.
Diagrams of the cervix, vaginal fornices, and the proximal portions of the
uterine horns were made and the location and extent of the different epithelial
lesions, to be described later, were plotted (Figs. 1 and 2). To facilitate
description the lesions were classified in four groups or stages. Stage 4
* The estrone benzoate was obtained from the Laboratoire Frangois de Chemo-
therapie, Paris. The estradiol benzoate was supplied by Dr. E. Schwenk of the
Schering Corporation (Progynon B). The equilin, equilin benzoate, and equilenin
benzoate were supplied by Dr. A. Girard, Paris. The estradiol dipropionate
(Di-Ovocylin) was supplied by Dr. E. Oppenheimer of the Ciba Pharmaceutical
Laboratories. The stilbestrol was supplied by Dr. J. A. Morrell of E. R. Squibb
and Sons. The progesterone (Proluton) and testosterone propionate (Oreton)
were supplied by Drs. E. Schwenk and M. Gilbert of the Schering Corporation.
The writers wish to express their appreciation for the generous assistance of the
above commercial and research laboratories in facilitating these investigations.
214SEX HORMONES IN GENITAL CARCINOGENESIS
includes lesions of demonstrated malignancy or those considered malignant
from histological examination. These lesions were usually large and involved
extensive areas in the genital
tissues. Lesions of stage 3 were
usually smaller and less anaplastic
in appearance though they had
invaded quite extensively. They
could not be considered as defi-
nitely malignant. Lesions of
stages 2 and 1 were smaller
though definitely invasive. Dur- --
ing normal sexual life the genital S
tissues show marked changes
which have been previously des-
cribed."0 These physiological
variations have been taken into
consideration. The lesions re- FIG.
ported here were definitely out- tmion
side the normal range. tissue
locati(
Observations tairoeas.
One hundred female mice C3H s
of the C3H strain were given graph,
variable amounts of several horn.
FIG. 2. A diagram presenting the irregu-
lar foldings of the epithelium of the cervix
and vagina in mice receiving estrogens and
androgens simultaneously (compare with Fig.
1) and showing the location of epithelial in-
vasions found in CH strain mouse 3, Table 9.
;. 1. A diagram of the uterine cervix of a
e in longitudinal (A) and cross (B) sec-
'see Fig. 6 for a photograph of the genital
s). On such diagrams the extent and
tons of the epithelial lesions (stippled
were plotted from the serial cross-sec-
This diagram presents the site and
t of a stage 3 invasion occurring in a
strain mouse. Figs. 9 and 10 show photo-
s. F-vaginal fornices, C-cervical canal,
osterior lip of cervix, U-lumen of uterine
different estrogenic chemicals
at one or several different dose
levels (Table 2). Some of
the series were very small;
either comparatively few
females were used or some are
yet living.
Mice of the C3H strain
tolerate treatment with estro-
gens quite well as they sur-
vived treatment for an average
of 264 days (Table 1). Fifty-
six of the mice died with
mammary, lymphoid, or
spindle-cell tumors. The com-
paratively high-tumor inci-
dence tends to decrease the
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TABLE 1
SUMMARY OF DATA ON THE INCIDENCE OF CERVICAL LESIONS IN MICE
RECEIVING ESTROGENS
e
b c d Average f
No. offemales No. No. of uterine periodof Averageperiod
a oninjection adequately or cervical injection of injection
Strain experiments studied lesions of columnc ofcolumnd
C8H 100 76 10 264 339
CBA 35 26 10 319 442
C12I 30 19 5 192 191
A 27 23 2 200 197
C57 21 15 0 181 ...
N 22 14 0 161 ...
JK 10 6 0 204
F 4 4 0 74
Totals 249 183 27
average survival time. Of the 100 mice treated, the genital tissues
of 76 were sectioned and studied microscopically. The other 24
mice were autopsied, but post-mortem autolysis prevented adequate
histological examination.
The uterine cervices or vaginal fornices of 10 of the 76 mice
adequately studied showed variable amounts of epithelial invasion.
These 10 mice survived for an average of 339 days following the
first injection, or 75 days more than the average of all autopsied
mice. One of these lesions was a transplanted, metastasizing tumor
previously described,9 which arose in a mouse killed at 364 days of
age. This lesion extended through the entire cervix, the greater
part of the vaginal wall, the rectum and adjacent pelvic tissues,
and to the lumbar lymph nodes. The tumor was composed of
invading cords of cells. It grew rapidly following transplantation
to both males and females which were not treated with estrogens,
and was carried for 3 transplant-generations.
The second tumor considered malignant (stage 4) in our series
was much smaller, involving one-half of the cervix and the imme-
diately adjacent posterior vaginal wall just below the posterior lip
of the cervix. This lesion was composed in part of cysts lined by
stratified cells and in part of cords of cells which had completely
penetrated the cervical wall (Fig. 3). These cell cords presented
216TABLE 2
SUMMARY OF THE DATA ON MICE OF THE C8H STRAIN RECEIVING ESTROGENS
Level of o R.s treatment
DPB*
50 6 4 2
S
25 1 1 -
E
100 4 4 -
EB
100 3 3 -
ENB
100 6 5 1
B
50 12 12 -
B
10 6 6 -
B
33.3 8 7 1
B
33.3 X 8 6 2 4
B
33.3/2X8 8 4 4
33.3/4 3 2 1
B
16.6/4 6 6 -
B
16.6/3 2 2 -
B
16.6/2 2 2 -
B
3.3 4 2 2
B
16.6 15 10 5
B
8.3 2 1 1
EBC
100 6 3 3
Totals 100 76 24
_ Cervical
Averageperiod invasion:
b treated (days) Stages Uterineresponsest
X Sect. Not sect. TumorsIf 1 2 3 4 Cystic Hyalin Pyo. Meta.
187 267
279
292
260
209
208
229
272
356
219
384
326
341
229
254
259
267
366
255
67
313
299
300
201
357
300
335
2 L.
2 L. Sa.
1 M. Ca.
1 M.Ca.
Sa.
1 M. Ca.
3 M. Ca.
1 L. Sa.
3 M. Ca.
5 M.Ca.
2 M. Ca.
4 M. Ca.
6 M. Ca.
4 M. Ca.
2 M. Ca.
2 M. Ca.
3 M. Ca.
7 M. Ca.
5 M. Ca.
49 M. Ca.
1 Sa.
6 L. Sa.
1
1
1
1
1 -
- 1
1 1
1
_ _ _
_ _ _
_ _ 1
_ _ _
_ _ _
_ _ _
_ _ _
_ _ _
4 2 2 2
4 _
1 - _ _
1 3 - _
3 _
5 _
1 10 1 2
5 _
1 7 -
- 2 1 -
2 - _ _
1 1 - -
1 8 1 -
2 _
3 _
* DPB=estradiol dipropionate EBC=equilin benzoate+cortin S=stilbestrol B=estradiol benzoate E=equilin 33;3 X8=33.3'Yweeldy for 8 weeks and no further injections EB=equilin benzoate 33.3/4=33.3Yevery fourth weekthroughout life ENB=equilenin benzoate 33.3/2X8=33.3Yevery second week and treatment stopped after 8 injections:
t L.=Leukemia L. Sa.=Lymphosarcoma M. Ca.=Mammary adenocarcinoma Sa.=spindle-celled sarcoma at site of injection
t Pyo.=Pyometra Meta=Metaplasia
I
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a more anaplastic picture than did those found in lesions of the lower
grades. Again the point of origin could not be adequately deter-
mined though it must have been either the wall of the cervical canal
or the cervical wall of one of the fornices. This mouse had received
weekly injections of 100y of equilenin benzoate for 282 days.
Lesions rated stage 3 were observed in two mice of the C3H
strain. One mouse had received 50y of estradiol benzoate weekly
for 313 days starting at 29 days of age, and the second had received
33.3y weekly for 345 days starting at 46 days of age. Both lesions
involved the greater part of one-half of the cervix and apparently
arose either from the wall of the cervical canal, the external os, or
the outer cervical wall. They consisted of cords of epithelial cells,
the larger cords of which were filled with cellular debris (Figs. 1,
4, and 10).
Six lesions of stages 2 and 1 were observed in the C3H-strain
mice receiving estrogens. Those of stage 2 showed a slightly greater
invasive tendency than did those of stage 1 (Fig. 5). The points
of origin of these 6 epithelial irregularities were again the wall of
the cervical canal, the external os, or the outer cervical wall. The
lesions were usually found in mice treated for from 300 to 400 days
(Tables 2 and 3).
TABLE 3
SUMMARY OF THE CERVICAL TUMORS IN MICE OF C3H STRAIN RECEIVING ESTROGEN
Grade cervical lesion No. of lesions Period of treatment
1 4 317-342-423-347
2 2 347-268
3 2 313-345
4 2 282-364
The upper vagina and cervix of the mice tended to vary in size
and microscopic structure depending upon the dose and the duration
of treatment with estrogens. The mice receiving the larger doses
usually had large cervices and thick vaginal walls (Fig. 6). Upon
gross observation they were regular in shape, even in those mice
showing the smaller lesions, fibrous or hard, and whitish in color.
Histologically, they showed an increase in fibromuscular tissue
(Fig. 7). Frequently this tissue was extremely loose and edematous
and in some cases resembled mucoid tissue (Fig. 8). In the mice
receiving the larger doses, the cervical canal was usually small
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(Fig. 7) and epithelium of a low stratified squamous type lay over
a thickened, regular, and somewhat hyalin basement membrane
(Fig. 9). An accumulation of round cells lay beneath the basement
membrane in some places (Fig. 9) or throughout in many of these
mice. Occasionally, a hyalin-like transformation appeared in the
stroma of the cervices of such intensively treated mice, particularly
in the upper portion, possibly progressing from the uterus.
To a certain extent similar changes occurred in the vagina. The
mucosa usually was much less folded than in untreated or in estro-
gen-androgen treated animals giving the epithelium a more regular
appearance (Fig. 9). The epithelium on the outer cervical wall
was usually of the low stratified type,-very rarely cornified in con-
trast to the more frequently cornified layer on the opposing vaginal
wall. Again, the basement membrane was thickened and hyalin-like
in many instances, and round cells and at times leukocytes had accu-
mulated in the mucosa. The greatest vaginal cornification was found
in the mice treated for the shortest intervals, or in some of the mice
receiving the monthly injections.
The cervices and vaginas differed strikingly from those of old
mice which became extremely atrophic and also from those of mice
showing a marked hyperplasia and hyperemia within a few days
after the onset of injections. Marked hyperplasia and hyperemia
were not observed in the chronically treated animals.
Malignant changes were not observed in the uterine horns of
any of the mice. Two mice showed tumorous lesions, one a possible
granuloma or fibroma in a uterine horn involved in a pyometra and
one a subserosal accumulation of large unidentified cells.
The condition of the uterus depended greatly on the duration
and intensity of treatment and the age at which the injections were
started. Pyometra developed infrequently in mice of the C3H
strain. Complete metaplasia occurred only in animals in which the
injections were started at a very early age (Fig. I1). The stroma
showed a slight hyalin transformation and some fibrosis. Few or
no glands were present, and the uteri were very small (Fig. 11).
Cystic uteri wereinfrequently found in these mice and even when
so classified showed no pronounced cystic condition. A hyalin
degeneration of the stroma occurred with great frequency and
tended to progress with the duration of the treatment (Fig. 12).
The hyalin change tended to follow a rather characteristic pattern,
appearing first as two areas on opposite sides of the mesometrium
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and progressing toward the antimesometrial endometrium on each
side, apparently replacing some of the glands. A more cellular
layer infiltrated with round cells and occasionally containing macro-
phages usually separated the basement membrane from the hyalin-
ized areas (Fig. 12). The entire mucosa appeared quite avascular
-in such cases. Rarely did the hyalin change tend to encroach upon
the muscularis. The stromal hyalinization persisted for several
months after the injections of estrogen were stopped in 2 instances.
The uterine epithelium was of the usual columnar or pseudo-
stratified columnar type (Fig. 11). The number of cells in mitosis
was never striking, except in some of the animals receiving the inter-
TABLE 4
SUMMARY OF DATA OF MICE OF THE CBA STRAIN RECEIVING ESTROGENS
Cervical
Level of o * a Average invasion:
treatment o v o period treated Stages Uterine responses
tr c% w 2;Sect. Not sect. Tumors 1 2 3 4 Cystic Hyalin Pyo. Meta.
33.3 2 2 0 94 - _ _ _ - - 1
16.6 19 10 9 325 283 1 L. Sa. - 2 - - 4 8 4 2
5 M. Ca.
8.3 12 11 1 355 296 1 L. Sa. 1 2 2 - - 2 5 -
7 M. Ca.
16.6/2*| 2 2 0 523 - 2 M. Ca.1- 1- 1 1 1
* 16.6 every second week
rupted treatment or treated for shorter periods. Stromal hyaliniza-
tion infrequently occurred in such animals as well. Small vacuoles
or areas containing the debris of one or more epithelial cells were
very often found in the epithelium (Fig. 12). An eosinophilic
material was frequentlyobserved in the lumens of the small or cystic
glands. Leukocytic invasion, except in the 3 instances of pyometra,
was seldom observed.
The uterine tubes of mice receiving estrogens likewise showed
definite changes. The fimbria were never strikingly altered, but the
epithelium of the body of the tube became pseudo-stratified. The
cells enlarged and the nuclei were placed toward the luminal border
of the cells (Fig. 13). Ciliated cells were lacknig. The stroma
apparently was slightly increased.
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Estradiol benzoate, in amounts ranging from 33.3y to 8.3y, was
injected weekly into 35 female mice of the CBA strain (Table 4).
The experiments were started in mice ranging in age from 2 to 63
days and were continued until tumors developed or until death
occurred from other causes. The genital tissues of 26 of the animals
were sectioned and studied microscopically. Ten of the 26 mice
showed epithelial lesions, rated stages 1 to 3 (see Tables 4 and 5),
of the cervix, vaginal fornices, or utero-cervical junctions. Two
areas of epithelial irregularity were observed in each of 3 mice and
a single area in each of the other 7 animals.
TABLE 5
SUMMARY OF CERVICAL LESIONS IN CBA STRAIN MICE RECEIVING ESTROGENS
Cervical invasion: Average period
Stages of treatment No. of lesions
1 390 3
2 488 4
3 538 3
4
Mice of the CBA strain tolerated the injections of estrogen quite
well. The average survival time following the start of the experi-
ments was 319 days. This was appreciably longer than in mice
of the C3H strain and was in part attributable to the later appear-
ance of mammary tumors in the CBA mice. The average survival
time of mice of the CBA strain showing cervical lesions was 442
days, or over 100 days more than that of mice of the same strain
showing no lesions of the cervical epithelium (Table 5), and over
100 days longer than that of the mice of the C3H strain showing
epithelial invasions or cervical carcinomas.
Five mice were first given estrogens at from 2 to 9 days of age
and survived for from 309 to 490 days, all dyingwith either medias-
tinal sarcomas or mammary adenocarcinomas. One of these mice
showed 2 small invadingepithelial growths. The uterine epithelium
of 2 of these mice had undergone complete metaplasia, becoming
stratified squamous. The experiments were started at from 31 to
63 days of age in the other 30 mice and complete uterine metaplasia
was observed in only one instance.
The uterine cervical lesions for the most part were comparable
to those in the C3H strain. In all except 3 mice the lower cervical
canal was involved. In one of these mice a very small lesion
(stage 1) occurred on the cervical wall of one of the lateral fornices;
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in the second a large tumor (stage 3) was present in the upper
cervical canal and involved the lower uterine horns; and, in the
third a few small cords of epithelial cells invaded the mucosa
(stage 1) at the utero-cervical junction. A small adenocarcinoma-
tous lesion was present in another mouse which also showed a
squamous-cell invasion of the epithelium of the cervical canal and
external os.
Pyometra developed in 11 animals of this strain. The inflam-
matory process was usually localized in one horn or part of one
horn and resulted in a large abscess. A slight leukocytic infiltration
was present occasionally throughout the rest of the uterus. In
nearly all animals some leukocytic invasion occurred in the lower
TABLE 6
SUMMARY OF DATA ON MICE OF THE C12I STRAIN RECEIVING ESTROGENS
| ji >,3 .4 l I Cervical Level of J:Z . Average invasion:
treatment o X period treated Stages Uterinereactions
y % c Sect. Not sect. Tumors 1 2 3 4 Cystic Hyalin Pyo. Meta.
16.6 22 14 8 147 182 3L. Sa. 2 1 1 - 4 2 8 4
iSa. 3 - - -
16.6/3* 4 3 1 363 153 2 M. Ca. - - - - 2 1
8.3 4 2 2 252 207 1 - _ _
* 16.6 every 3rd week
part ofthe uterine horns just above the cervix. The points of transi-
tion between the stratified cervical epithelium and columnar uterine
epithelium were extremely irregular. In this region localized areas
of glandular tissue interspersed with areas of dense hyalin tissue
usually replaced the normal mucosa and frequently encroached upon
the myometrium. The extreme reaction at the utero-cervical junc-
tion was quite characteristic of this strain. The extent of uterine
hyalinization tended to increase with the duration of treatment
(Fig. 14).
Thirty female mice of the C12I strain were given estradiol
benzoate at 3 different levels, 16.6y or 8.3y weekly or 16.6y
every third week (Table 6). Nineteen of these mice were autop-
sied and the genital tissues were sectioned for microscopic study.
The other 11 mice were examined after death and no tissues were
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saved. Of 22 mice given 16.6y of estradiol benzoate weekly,
14 were autopsied after from 78 to 217 days of treatment-average
147 days. Epithelial irregularities of variable extents were found
in 5 of these mice (Table 7) after treatment of from 147 to 203
days. The most extensive lesions appeared in a mouse treated for
a period of 198 days. All of these mice, with the exception of the
one showing the stage 3 lesion, had pyometra involving one or both
horns of the uterus. In the latter mouse polymorphonuclear cells
were found in the uterine lumen and in the walls, but the extent of
infiltration was insufficient to demonstrate an active inflammatory
condition.
Two areas of epithelial irregularity were observed in the cervices
of each of 2 mice of this strain. In both cases one lesion occurred in
the cervical canal and another at the lower portion of one of the
TABLE 7
SUMMARY OF CERVICAL LESIONS IN MICE OF THE C12I STRAIN
Cervical invasions: Average period Number of mice
Stages of treatment showving lesions
1 203 3
2 147 1
3 198 1
lateral fornices. The lesions were rated stage 1 in both instances.
One lesion occurred in each of the other 3 mice, in 2 cases involving
only the lower cervical region and in one case the lower lateral and
posterior lip of the cervix and the immediately adjacent posterior
vaginal wall (stage 3). This lesion apparently arose in the cervical
wall or in one of the vaginal fornices. Histologically, it was com-
posed of solid cords of squamous epithelial cells and alveolar-like
structures lined by a squamous epithelium and filled with desquam-
ated cells (Fig. 15). The cervical epithelium was absent in several
places and the exposed surface of the epithelial invasion was heavily
infiltrated with leukocytes.
The cervices of all of the mice receiving the large amounts of
estrogen were large, usually white, and fibrous. The cervical canals
were usually very small, occasionally almost closed, the low strati-
fied squamous epithelium ofthe opposing walls being fused through-
out the greater portion.
The uterine horns of mice of this strain presented no evidence
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of neoplastic changes. Cystic hyperplasia predominated in the mice
receiving the smallest amount ofestrogen. The uteri of mice receiv-
ing the 2 larger doses presented pictures of pyometra and in 4
instances metaplasia. In some presenting a slight cystic condition,
local hyalin areas were scattered throughout the endometrium.
Twenty-seven female mice of the A strain were given either
SOy of estrone benzoate weekly or 16.6y of estradiol benzoate
weekly for periods up to 355 days. Injections were started in 19
mice from 1 to 9 days and in the other mice at 25 to 40 days of
age. The uterine horns were removed from 3 mice prior to the
administration of estrogen.
The mice receiving estrogens starting when very young
responded in a fairly constant manner. The uterine cervices were
all tremendously enlarged, firm, and whitish in color (Fig. 6).
The uterine horns were small, 1 to 1.5 mm. in diameter, white, and
firm. The cervix, histologically, showed hypertrophy of the fibro-
muscular tissue and an edematous or mucoid transformation of the
stroma (Fig. 8). The epithelium was usually of the low stratified
type. The uterine epithelium of many of these animals was also
stratified squamous, and comparatively few glandular structures
were present. The uterine stroma was either fibrous or diffusely
hyalinized. The myometrium was poorly developed. Even the
mice which received estrogens starting at 25 days of age had small
uteri. The epithelium was stratified in only oneinstance. Pyometra
was observed in only 3 mice.
The vaginal and cervical epithelium was of the stratified squa-
mous type in all animals. Comparatively little cornification occurred
in animals treated for 150 days or more. The basement membrane
was distinct and quite regular in all except one animal.
Of the 3 animals from which both uterine horns were removed
down to the point of bifurcation 2 showed at autopsy, 198 and 194
days after the first weekly injection of 16.6y of estradiol benzoate,
invasive epithelial lesions (stages 2 and 4). A lesion considered to
be a carcinoma was found in one of these mice. The tumor extended
from the utero-cervical junction about one-third of the way down
the vagina, involving and enlarging one-half of the cervix and the
upper vaginal wall. The loose connective tissues surrounding the
vagina were also involved, as was the dorsal wall of the urethra.
The tumor was composed of stratified squamous cells arranged in
cords and small cysts lined by partially keratinized epithelium and
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containing desquamated cells and leukocytes. The peripheral cells
presented a more anaplastic picture and were arranged in smaller
invading cords. The remaining upper part of the uterus was
apparently infected and had formed a small abscess.
The second epithelial invasion was located at the utero-cervical
junction. Small cords and scattered epithelial cells had invaded
the underlying mucosa and outer denser fibromuscular layer. This
lesion was more directly associated with an inflammatory process as
the greater part of the remaining uterus was involved in an abscess.
Estradiol benzoate was given to 21 female mice of the C57 strain
in amounts of 50y, 16.6y, or 8.3y weekly over variable periods of
time. The genital tissues of 15 of these mice were studied micro-
scopically. No lesions were observed in the cervices or upper
TABLE 8
SUMMARY OF DATA ON MICE OF THE A STRAIN RECEIVING ESTROGENS
Cervical
Level of z 4 Average invasion:
treatment o c o period treated Stages Uterine responwes
y 2 y Sect. Not sect. Tumors 1 2 3 4 Cystic Hyalin Pyo. Meta.
50 12 10 2 174 157 4 M. Ca. - - - - 2 5 6 2
16.6 15 13 2 220 209 1 L. -1-1 - 9 - 8
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 2 M. Ca.
vaginas. The uteri were either very large and cystic or involved
in a pyometra. The average survival time was only 181 days, as
females of this strain have tolerated injections of estrogen poorly.
Twenty-two female mice of the N strain were given subcutane-
ously estrogens in oily solution for variable periods. These mice
tolerated estrogen in large amounts (SOy weekly) very poorly, 9
mice dying after an average period of treatment of 82 days. Most
of these mice died with pyometra. Four hysterectomized mice
receiving comparable treatment survived nearly four times as long
(233 days). The uteri were transformed to large abscess-like
masses and were involved in multiple adhesions to the peritoneum.
The uteri of the 9 mice receiving the smaller amounts of estrogen
(16.6y every other week or 8.3y weekly) did not show pyometra at
autopsy. The epithelium was ofthe columnar type. The connective
tissue of the endometrium was largely transformed into a fibrous
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and hyalin mass without the usual infiltration of round cells around
the scattered glands.
Epithelial irregularities in the cervix or upper vagina were not
observed in any of the animals. The cervices were generally not as
enlarged as in mice of other strains.
The absence of infiltrative lesions of the cervix cannot be
attributed, however, to any specific difference in uterine response.
Few animals survived for a sufficiently prolonged period.
Ten female mice of the JK strain received weekly injections of
from 8.3y to 5Oy of estradiol benzoate for variable periods ranging
up to 334 days, starting at ages ranging from 35 to 77 days. The
uteri ofthe mice receiving 8.3y or more of estradiol benzoate weekly
all showed extensive hyalinization of the endometrial stroma.
Epithelial metaplasia appeared in one mouse showing pyometra.
Epithelial irregularities were not observed in the vaginas or cervices
of any of these mice. Estradiol benzoate was administered at the
rate of 50y and 100y weekly to 4 female mice of the F strain. All
of these mice developed pyometra and died after a period of from
62 to 87 days. In one mouse the uterine epithelium was entirely
removed by the inflammatory mass. In the other 3 mice metaplasia
was complete or irregular throughout the uterine horns. The cer-
vices were greatly enlarged by a proliferation of fibromuscular
elements and edema. The vaginas were lined by thickly stratified
squamous epithelium but showed little cornification. The walls of
the cervical canals were thickly stratified and the outer layers were
slightly cornified.
Estradiol benzoate and testosterone propionate have been admin-
istered simultaneously to mice of several strains, but thus far suffi-
cient numbers have survived over long periods in only two strains
(C3H and C12I) to warrant discussion. Eight female mice of the
C3H strain have been autopsied after periods of treatment of from
161 to 431 days. Of this number the tissues of 6 have been ade-
quately studied. One mouse had a large tumor extending from the
distended vagina. At autopsy, tissue from the tumor was trans-
planted into 4 other mice of the same strain. One of the 4 mice
developed a tumor at the site of transplantation but the tissue was
misplaced in the process of cutting and was never observed micro-
scopically. The other 3 mice have not shown any growth of the
graft. A tumor was detected at autopsy in a second mouse but was
not transplanted. These mice are listed individually in Table 9.
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All of the mice receiving weekly, in 2 injections, 2.5 mgm. of
testosterone propionate and 16.6y of estradiol benzoate showed strik-
ing lesions, two of which were mentioned above. The other 2 mice
showed lesions of stages 1 and 3.
The genital tracts of the mice so treated differ appreciably from
those of animals receiving estrogens. The cervices and upper
TABLE 9
INVASIVE-EPITHELIAL LESIONS IN MICE OF THE C8H AND C121 STRAINS GIVEN VARYING
AMOUNTS OF ESTRADIOL BENZOATE AND TESTOSTERONE PROPIONATE
Age
injections Period Amountweekly Total amount
started treated T.P.* T. P.
Mowse (days) (days) mgm. B mgm. B Tumors Lesions
C H
1 24 232 1.25 16.6 80 533 _ Notsect.
2 24 336 1.25 16.6 113.75 766 None
3 54 161 1.25 33.3 30 833 - Not sect.
4 61 336 2.5 16.6 117.5 783 M. Ca. Stage 3
5 61 235 2.5 16.6 825 550 M.Ca. Stage 1
6 61 291 2.5 16.6 107.25 716 - Stage 4
7 61 421 2.5 16.6 152.5 1016 L. Stage 4
8 40 182 .625 16.6 16.25 433 None
C12I
1 56 403 1.25 16.6 68.75 950 None
2 56 276 1.25 16.6 48.75 650 None
3 42 411 1.25 33.3 72.5 1933 Stage 3
4 42 172 1.25 33.3 30 800 - None
* T. P. = Testosterone propionate; B = estradiol benzoate.
vaginas were less enlarged (except in the 2 showing large tumors).
The uterine horns were either very small, or they were soft, pliable
and slightly enlarged.
Microscopically, the uteri were lined by a low columnar
epithelium. The number of glands was apparently decreased. The
stroma was fibrous, coarse collagenous fibers replacing the cellular
and finely fibrillar structure of the normal uterus. The muscularis
was usually quite well developed, as was the vascular intermuscular
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layer. The cervical canal was very large (Fig. 2). The low,
stratified, pseudo-stratified, or even tall columnar epithelium lining
the canal was thrown into folds making the basement membrane
extremely irregular (Fig. 16). Evidences of abnormal epithelial
invasion occurred in the cervical canal of only 2 mice (3 and 7,
Table 9). The folding of the epithelium increased toward the
external os.
The vaginal walls of the cervices were lined by a low stratified
epithelium showing an increased tendency to be thrown into folds,
but usually more regular than the opposite vaginal walls (Fig. 17).
Extreme folding occurred in the vaginal epithelium. The lesions
observed in the 4 mice all occurred from such an epithelium.
The cervical stroma was composed of amoderately cellular tissue.
The basement membranes were delicate and not thickened as in many
of the estrogen-treated mice. Except in the areas of infiltration the
stroma contained few round cells or leukocytes.
The lesions of all of the mice receiving the larger amounts of
testosterone were characteristically different from those of mice
receiving estrogens alone (Figs. 18-21). The invading cells,
arranged in alveolar structures or cords, showed litde stratification
and no cornification. The peripheral portions of the two larger
tumors were composed of more solid cords (Figs. 19 and 20). The
larger ones, though not extending into the remote pelvic tissues,
had completely invaded the vaginal wall, as had the smaller lesion
ofstage3 (Fig. 18).
Four mice ofthe C12I strain also received similar treatment. The
response of the genital tissues was much the same as was that of the
C3H strain receiving similar treatment. Epithelial invasions were
observed in but one mouse. This animal had received 33.3y of
estradiol benzoate and 1.25 mgm. of testosterone propionate weekly
and survived for 431 days. Four separate epithelial invasions were
present involving the cervical canal, vaginal fornices, and vaginal
walls (stage 3). The structure of the invasive cords in this mouse
closely resembled that of the mice receiving estrogens. The large
folded and open cervical canals of these mice contrasted strikingly
with the condition observed in animals of the same strain receiving
estrogens alone. It is also interesting that these mice lived on the
average of about 120 days longer than did the mice receiving estro-
gens alone, even though some of the latter groups received much
smaller amounts of estrogens.
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Estradiol benzoate and progesterone were injected into 2 female
mice of the C3H strain and 4 mice of the N strain. The 4 mice of
the N strain received 6.66y of estradiol and 800y of progesterone
weekly for from 67 to 176 days. Three of the mice died with
pyometra. The uterine, cervical, and vaginal changes were not
sufficiently different from those of the estrogen-androgen treated
mice to merit extensive description. The cervical canals tended to be
larger and the epithelium more extensively folded in the vaginal
and cervical walls. Epithelial invasions were not observed.
The 2 mice of the C3H strain received 16.6y of estradiol ben-
zoate and 200y of progesterone weekly for 123 and 273 days. An
extensive epithelial invasion involving the entire cervix occurred in
the mouse treated for the longer period. This lesion was rated as
stage 3. Histologically, it was quite similar to the epithelial inva-
sions which occurred in the estrogen-treated animals. The vaginal
and uterine picture was quite like that observed in the mice receiving
estrogen and testosterone simultaneously. The vaginal and cervical
epithelium was extensively folded. Hyalinization of the uterine
stroma was not observed.
Controls
The genital tissues of 31 female mice of the C3H strain were
examined following the injection of sesame oil, cholesterol, or
cholesterol benzoate in solution in sesame oil. These mice survived
for periods of from 152 to 675 days, averaging 382 days. In addi-
tion, observations were made on 17 untreated mice of the C3H
strain from 148 to 492 days of age, 24 mice of the CBA strain from
150 to 723 days of age, 9 A-strain mice from 133 to 356 days of
age, 13 N-strain mice from 152 to 427 days old, and 10 JK-strain
mice from 107 to 483 days of age. A total of 104 mice, untreated
or treated with non-estrogenic materials, was thus studied. Serial
sections of the uterus, cervix, and upper vagina were not made in
many cases, but test sections of the tissues were cut. The gross
appearance of the uteri and cervices varied greatly as might be
expected, from small atrophic organs to fully developed hyperplastic
structures. The variability was greatest in the tissues in the older
animals. In no instance, however, were lesions found that might be
considered comparable to those described in the mice receiving estro-
gens or estrogens and testosterone. As described by others, the
vaginas and cervices of the older animals tended to show increased
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folding which added to the irregularity of the basement membrane
as well as to the increase in papilla. There was, however, no indi-
cation in our material that epithelial invasion had occurred as in the
treated mice.
Discussion
Several factors of significance in relation to the development in
the uterine cervix and upper vagina of carcinomas and cancer-like
lesions which appear to be early stages of a malignant change arise
from the investigations undertaken. The role of estrogens in mam-
mary carcinogenesis in mice has been complicated by the co-existence
of intrinsic factors apparently transferred from parents or parent to
offspring. This complicating factor does not exist, so far as is known,
for tumors of the uterus or cervix. Uterine tumors, particularly
epithelial tumors, rarely develop in mice as found by observations in
other laboratories." The absence of invasive lesions in the 104
untreated or non-estrogen treated mice in this study also indicated
their rarity.
As in the mammary glands, estrogens induce profound prolifera-
tive changes in the uterus and vagina. With continuous treatment
the hyperplastic processes recede even though treatmentis continued,
with certain exceptions. In the mammary glands, localized areas
undergo proliferation resulting in hyperplastic nodules of mammary
tissue. These nodules may resemble small adenomas which appear
in some cases to undergo malignant changes,'2 possibly even in the
absence of further estrogenic stimulation. Likewise, in the more or
less static cervices of mice receiving extensive estrogenic treatment
one or more areas appear to undergo certain changes leading to an
epithelial invasion of the deeper tissues. Though the smaller epi-
thelial lesions present little evidence, in some ways, of malignancy,
they form a series of intermediate stages of increasing extent, finally
culminating in carcinoma. In mice that have been selected for many
generations for a tendency to develop mammary tumors, only com-
paratively brief estrogenic treatment is necessary before mammary
adenocarcinomas develop in males. Longer periods of treatment
are required in strains showing a lower incidence of mammary
cancer.'3 In certain strains of mice, mammary tumors were not
observed followingthe injection ofestrogens.5 Strangely, mice from
the strains more resistant to the spontaneous mammary tumors
tolerated estrogenic stimulation least satisfactorily (see Table 1,
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strains C57, N, JK, F). They survived for periods too brief for
mice of the highly susceptible mammary tumor C3H strain to
develop breast tumors.
The cervical epithelial invasions and tumors appeared at a later
average age than did the mammary tumors and at a lower incidence.
For instance, one mouse with a malignant transplantable cervical
tumor had had its life prolonged by twice removing mammary
tumors. In the C12I strain the cervical lesions tended to appear
comparatively early, a point that might be of interest in further
investigation. However, the absence of lesions in mice of the other
strains, N, C57, JK, and F, cannot be taken as indicating the lack of
response to estrogens, as their survival was of approximately equal
duration or was shorter than that of the C12I mice. Few mice from
these strains survived as long as any of the animals from the C3H
or CBA strains which developed invasive lesions of the cervix.
Because of the small number of animals in certain groups and the
absence of one or more levels of treatment in several strains, an
indication of the most effective level of treatment cannot yet be
stated. Likewise, insufficient data are available to determine whether
interrupted doses or continuous treatment is most satisfactory for the
experimental development of cervical or uterine lesions of a can-
cerous nature. From the data available the duration of the period
of treatment rather than the amount seems to be of greater
significance.
The extremely high incidence of cervical or upper vaginal
tumors and epithelial lesions in mice receiving one level of estrogen-
testosterone treatment might be of great interest. Though the data
are limited, it appears that other levels with larger amounts of estro-
gen in relation to the amount of testosterone may give different
results. Unlike the tendency for localization of the early lesions
apparent in the estrogen-treated mice at one or two areas, the
lesions in the animals receiving the two hormones tend to be more
diffuse or generalized. The atrophic changes in the stroma are
largely inhibited even in those mice which received amounts of the
two hormones that did not give rise to tumors in the experiments
reported here.
The influence of testosterone on inhibiting spontaneous mam-
mary tumors in female mice has been reported.14 It will not com-
pletely inhibit breast tumors in mice receiving estrogens (see
Table 9), as was also observed by Lacassagne."5 It is interesting
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that in the estrogen-androgen experiment reported here the number
of cervical and vaginal tumors equaled the number of mammary
tumors and that in two other mice epithelial lesions occurred in the
upper vagina and cervix which were graded 1 and 3. It appears
that hormone balance may be significant in the establishment of
malignant processes and that these balances may differ for different
genital tissues or organs, in this instance the mammary glands and
uterine cervix or upper vagina.
At the present time, it does not seem desirable to state that such
experiments as those reported here demonstrate more than a proba-
bility that the above hormones play a significant role in the etiology
of spontaneous cancer of the organs involved in those species in
which they occur. The absence of such lesions in untreated animals
and their presence in the treated animals, however, certainly demon-
strate that directly, indirectly, or in combination with other factors
they play a significant r81e in experimental carcinogenesis. As far
as is known the malignancies of the uterine cervix or upper vagina
have not been obtained in experimental conditions following the
subcutaneous (systemic) application of any other chemical agent.
Vaginal or cervical carcinomas have, however, developed following
the local application of benzopyrene to castrated mice (Gardner,
unpublished). The epithelium of the vagina of castrated mice thus
appears to respond in much the same way as does the skin to this
carcinogenic chemical, but unlike the skin, it also responds to estro-
gens or estrogen-androgen treatment.
Mice of certain strains did not tolerate treatment with estrogens
as well as others. The factors causing death in some animals were
not determined. In some other animals known factors not relating
to the treatment are involved. Pyometra, hydronephrosis, renal
infections, hemorrhage, and other factors being studied are respon-
sible for the death of many of these animals and apparently
associated with the treatment involved.
Lesions of a malignant nature were wholly lacking in the uter-
ine horns, as has been previously emphasized.7' 16 The epithelial
metaplasia, pyometra, and stromal hyalinization have previously
been described. Lacassagne,3 however, has been the only investi-
gator who has observed a malignant change in the uterine horn of
a mouse. Some observations have indicated that uterine metaplasia is
associated with septicinflammatory reactions. Metaplastic epithelium
lined cystic glands showing leukocytic invasion. It was absent in
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transplanted uteri in animals given estrogens. The frequency of
epithelial metaplasia in the uteri of mice in which the injections were
started very early in life, however, cannot be considered to support
the soleinterpretation ofthis change as aresponse to septic inflamma-
tion. Though the material available does not preclude extension
of the stratified squamous epithelium of the cervix throughout the
uterus, no evidence of such a change was observed.
Summary
Estrogens in variable amounts were injected subcutaneously into
249 female mice from 8 different strains (C3H, CBA, A, C121, C57,
N, JK, and F). The genital tissues of 183 of these mice were
studied microscopically. Twenty-seven showed epithelial lesions of
the cervix or vaginal fornices. These lesions were found among
134 mice from 4 different strains (CBA, 10; C3H, 10; A, 2; and
C121, 5).
Three of the above lesions were considered to be carcinomas.
One was transplanted into other mice of the same strain. Six of
the lesions, though invading the cervical tissue extensively, were
considered as pre-malignant lesions. The other 17 lesions exhibited
slighter invasive tendencies but were epithelial irregularities unlike
any found in 104 untreated control mice.
The average period of treatment in 19 of the mice from 2 of the
strains, which developed the lesions significantly, exceeded that of
mice which did not develop lesions.
The development of cervical and upper vaginal lesions could
not be associated with the amount of estrogen given considering the
data as a whole.
Cervical or upper vaginal tumors or epithelial invasions did not
develop in 39 mice of the C57, N, JK, and F strains adequately
studied. These mice did not tolerate treatment for long periods.
These mice were from spontaneous low-mammary-tumor strains.
Four of eight mice from the C3H strain receiving estradiol ben-
zoate and testosterone propionate simultaneously developed cervical
or upper vaginal lesions, two of which were considered to be malig-
nant. One of the four C12I mice receiving the two hormones simul-
taneously developed four lesions of the cervical and vaginal
epithelium (stage 3).
One of six mice (four from the N strain and two from the C3H
strain) developed a large invasive epithelial lesion of the cervix
following the injection of estrogen and progesterone.
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The general responses of the uteri, cervices, and vaginas of the
mice given estrogens and androgens are described. The tendency
for uterine epithelial metaplasia was highest in mice in which the
injections were started during the first week of life or in older ani-
mals which developed pyometra. Pyometra developed most fre-
quently in mice from the N, C57, and F strains, but was not entirely
limited to any one strain.
Degenerative changes, hyalin and fibrous, appeared in the
uterine stroma and occasionally in the cervix. The uterine, cervical,
and vaginal epithelium was infrequently found to be in a hyper-
plastic state.
REFERENCES
1 Witherspoon, J. T.: Surg., Gynec., & Obst., 1935, 61, 743; Am. J. Obst. &
Gynec., 1936, 31, 173.
Burch, J. C., Williams, W. L., and Cunningham, R. S.: Surg., Gynec., &
Obst., 1931, 53, 338.
2 Nelson, W. O.: Anat. Rec., 1937, 68, 99.
Pfeiffer, C. A.: Anat. Rec., 1938, 70, 62.
For review see Gardner, W. U.: Arch. Path., 1939, 27, 138.
3 Lacassagne, A.: Compt. rend. Soc. biol., 1936, 121, 697.
4 Loeb, L., Burns, E. L., Suntzeff, V., and Moskop, M.: Proc. Soc. Exper.
Biol. & Med., 1936, 35, 320.
5 Gardner, W. U.: [In] Some fundamental aspects of the eancer problem:
symposium sponsored by the Section on Medical Sciences of the American
Association for the Advancement of Sciences, New York, Science Press,
1937, p. 67; Science, June 1937, supp. 4, p. 67.
6 Perry, I. H.: Proc. Soc. Exper. Biol. & Med., 1936, 35, 325.
7 Suntzeff, V., Burns, E. L., Moskop, M., and Loeb, L.: Am. J. Cancer, 1938,
32, 256.
8 Perry, I. H., and Ginzton, L. L.: Am. J. Cancer, 1937, 29, 680.
9 Gardner, W. U., Allen, E., Smith, G. M., and Strong, L. C.: J. Am. Med.
Asso., 1938, 110, 1182.
10 Allen, E.: Am. J. Anat., 1922, 30, 297.
11 Slye, M., Holmes, H. F., and Wells, H. G.: J. Cancer Research, 1924, 8, 96.
Also ref. 7 above.
12 Gardner, W. U., Smith, G. M., and Strong, L. C.: Proc. Soc. Exper. Biol. &
Med., 1935, 33, 148.
13 Bonser, G. M., Strickland, L. H., and Connal, K. I.: J. Path. & Bact., 1937,
45, 709.
Lacassagne, A.: Presse med., 1935, 43, 233.
14 Nathanson, I. T., and Andervont, H. B.: Proc. Soc. Exper. Biol. & Med.,
1939, 40, 421.
15 Lacassagne, A.: Compt. rend. Soc. biol., 1937, 126, 385.
16 Gardner, W. U., Allen, E., and Strong, L. C.: Anat. Rec., 1936, 64, 17
(suppl.).
Loeb, L., Suntzeff, V., and Burns, E. L.: Am. J. Cancer, 1938, 34, 413.rP..-
Wl;7 I j,
3
J. I-
v
. .1
FIG. 3. A section of the smallest invasive lesion considered malignant (stage 4).
Treatment: 3.2 mgm. of equilenin benzoate in 282 days. One-half of the cervix was
involved as well as the posterior vaginal wall. The epithelial invasion at the level
photographed extended beyond the cervix and passed through the vaginal wall. A
portion of one of the vaginal fornices is shown. X 105.
FIG. 4. An epithelial lesion involving the greater part of the lateral half of cervix
and the posterior lip (stage 3 lesion). The lesion consisted of hollow and solid cords
of cells showing a definite tendency to cornify. Treatment: 50-y of estradiol benzoate
weekly for 313 days, a total of 2.2 mgm. X 120.u7-I .\^1
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FIG. 5. Small epithelial lesion (stage 1) in lower cervical canal of a C3H-strain
mouse. Treatment: 33.3y of estradiol benzoate every fourth week for 342 days, a total
of 300-y. X 90.
FIG. 6. Genital tract of A-strain mouse. Treatment: 266-y of estradiol benzoate in
114 days, starting at 1 day of age. The uterine horns were small and white. The
cervix was greatly enlarged, firm and regular.
FIG. 7. Cross-section of upper cervical canal of a GH-strain mouse. Treatment:
50-y of estradiol benzoate weekly for 258 days, 1.8 mgm. total. The cervical canal was
very small, the opposing walls of the folded epithelium were apparently fused.
FIG. 8. A portion of the lower cervical canal shown in Fig. 6. The low stratified
epithelium overlies a distinct basement membrane. The stroma was loose, edematous,
and in places myxomatous. X 70.r%-- I. v * A
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FIG. 9. A portion of the cervical canal of CH-strain mouse.
Treatment: 33.3
of estradiol benzoate weekly for 345days, 1.4 mgm. total. See Fig. 1 for level of
photograph. The epithelium was stratified. The basement membrane was distinct,
thickened, and hyalin. A round-cell infiltration occurred beneath the basement mem-
brane. X 100.
FIG. 10. A portion of one of the vaginal fornices of the above mouse showing the
vaginal epithelium, the outer cervical epithelium, and the underlying epithelial invasion
(stage 3). Fig. 1 indicates level of photograph. X 100.
FIG. 12. Section of a uterine horn of a C3H-strain mouse. Treatment: 33.3'y of
estradiol benzoate weekly for 347 days, 1.433 mgm. total. The epithelium was pseudo-
stratified. Vacuoles, some containing cellular debris, were located in the epithelium.
The hyalin stroma was senarated from epithelium by a layer of cellular stroma con-
taining round cells. X 200..7X.h) 1.)q
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FIG. 11. A cross-section of a uterine horn of a C3H strain mouse. Treatment:
50y of estradiol benzoate weekly for 279 days, starting at 3 days of age, 1.95 mgm.
total. The stroma showed mixed hyalin and fibrous degeneration. The uterine epi-
thelium had undergone complete metaplasia.
FIG. 13. A uterine tube of the A-strain mouse in Figs. 6 and 8. The epithelium
was pseudo-stratified. The nuclei had migrated away from the basal portion of the cells.
FIG. 14. Uterine horn of a CBA-strain mouse. Treatment: 16.6&y of estradiol
benzoate weekly for 227 days, a total of 516y. The stroma had undergone extensive
hyalin degeneration. Some glands penetrated the muscle layers.
FIG. 15. A stage 3 epithelial lesion in the cervix of a C12I-strain mouse. Treat-
ment: 16.6-y of estradiol benzoate weekly for 198 days, total of 466y. The lesion
involved the lower cervix, posterior lip of the cervix, and adjacent vaginal wall.
15
4Z ..
1:wFIG. 16. A portion of the cervical canal (level indicated in Fig. 2). Treatment:
2.5 mgm. of testosterone propionate and 16.6y of estradiol benzoate weekly. The
epithelium was extremely folded but the basement membrane was distinct. The stroma
was composed largely of coarse collagenous fibers. Compare with Fig. 9. X 60.
FIG. 17. One vaginal fornix of the mouse described in Fig. 17. The vaginal
epithelium was extremely folded and of the low stratified type. The thinner, more
regular epithelium over the cervix was particularly thin over the one small area of
epithelial invasion. Photograph taken at the level indicated in Fig. 2. X 60.
FIG. 18. Larger invasive lesion (stage 3) in the vaginal wall of the mouse men-
tioned in Fig. 16. X 100.
-0FIG. 19. A malignant invasion lesion (stage 4) of GH-strain mouse 6 in Table 9.
This lesion involved the entire cervix and upper vagina. X 100.
FIG. 20. A portion of a large epithelial lesion (stage 4) showing the extent of
penetration of the vaginal wall and a section of the rectum. This lesion developed in
GH-strain mouse 7, Table 9. X 100.
FIG. 21. Another section of the carcinoma in the same mouse described in Fig. 20.
X 100.